Mankind Pharma Sees Significant Open Interest Surge Amid Increased Trading Activity

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 13,453 contracts, marking a notable rise of 3,741 contracts or 38.52% from the previous open interest of 9,712. This surge in open interest coincides with a trading volume of 69,579 contracts, indicating heightened activity in the stock.
In terms of price performance, Mankind Pharma has outperformed its sector by 4.23%, with a 1-day return of 4.34%. The stock has shown consistent gains over the past two days, accumulating a total return of 5.35% during this period. Today, it reached an intraday high of Rs 2,543.6, reflecting a 4.6% increase.

Despite this positive momentum, there has been a decline in investor participation, with delivery volume dropping by 72.57% compared to the 5-day average. Mankind Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong market position. The stock's liquidity remains robust, supporting trade sizes of up to Rs 4.88 crore. Overall, the increase in open interest highlights a notable shift in market dynamics for Mankind Pharma.